Literature DB >> 25070414

Risk assessment in the 21st century: roadmap and matrix.

Michelle R Embry1, Ammie N Bachman, David R Bell, Alan R Boobis, Samuel M Cohen, Michael Dellarco, Ian C Dewhurst, Nancy G Doerrer, Ronald N Hines, Angelo Moretto, Timothy P Pastoor, Richard D Phillips, J Craig Rowlands, Jennifer Y Tanir, Douglas C Wolf, John E Doe.   

Abstract

Abstract The RISK21 integrated evaluation strategy is a problem formulation-based exposure-driven risk assessment roadmap that takes advantage of existing information to graphically represent the intersection of exposure and toxicity data on a highly visual matrix. This paper describes in detail the process for using the roadmap and matrix. The purpose of this methodology is to optimize the use of prior information and testing resources (animals, time, facilities, and personnel) to efficiently and transparently reach a risk and/or safety determination. Based on the particular problem, exposure and toxicity data should have sufficient precision to make such a decision. Estimates of exposure and toxicity, bounded by variability and/or uncertainty, are plotted on the X- and Y-axes of the RISK21 matrix, respectively. The resulting intersection is a highly visual representation of estimated risk. Decisions can then be made to increase precision in the exposure or toxicity estimates or declare that the available information is sufficient. RISK21 represents a step forward in the goal to introduce new methodologies into 21st century risk assessment. Indeed, because of its transparent and visual process, RISK21 has the potential to widen the scope of risk communication beyond those with technical expertise.

Entities:  

Keywords:  exposure; framework; hazard; problem formulation; risk; risk assessment; risk policy; tiered

Mesh:

Substances:

Year:  2014        PMID: 25070414     DOI: 10.3109/10408444.2014.931924

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  24 in total

1.  Determination of chemical-disease risk values to prioritize connections between environmental factors, genetic variants, and human diseases.

Authors:  Marissa B Kosnik; David M Reif
Journal:  Toxicol Appl Pharmacol       Date:  2019-07-16       Impact factor: 4.219

2.  Stochastic modeling of near-field exposure to parabens in personal care products.

Authors:  Susan A Csiszar; Alexi S Ernstoff; Peter Fantke; Olivier Jolliet
Journal:  J Expo Sci Environ Epidemiol       Date:  2016-01-13       Impact factor: 5.563

3.  Incorporating human exposure information in a weight of evidence approach to inform design of repeated dose animal studies.

Authors:  Kelly Lowe; Jeffrey Dawson; Katherine Phillips; Jeffrey Minucci; John F Wambaugh; Hua Qian; Tharacad Ramanarayanan; Peter Egeghy; Brandall Ingle; Rachel Brunner; Elizabeth Mendez; Michelle Embry; Yu-Mei Tan
Journal:  Regul Toxicol Pharmacol       Date:  2021-10-29       Impact factor: 3.271

4.  Conceptual Framework To Extend Life Cycle Assessment Using Near-Field Human Exposure Modeling and High-Throughput Tools for Chemicals.

Authors:  Susan A Csiszar; David E Meyer; Kathie L Dionisio; Peter Egeghy; Kristin K Isaacs; Paul S Price; Kelly A Scanlon; Yu-Mei Tan; Kent Thomas; Daniel Vallero; Jane C Bare
Journal:  Environ Sci Technol       Date:  2016-10-18       Impact factor: 9.028

5.  High-throughput exposure modeling to support prioritization of chemicals in personal care products.

Authors:  Susan A Csiszar; Alexi S Ernstoff; Peter Fantke; David E Meyer; Olivier Jolliet
Journal:  Chemosphere       Date:  2016-08-24       Impact factor: 7.086

6.  APROBA-Plus: A probabilistic tool to evaluate and express uncertainty in hazard characterization and exposure assessment of substances.

Authors:  Bas G H Bokkers; Marcel J Mengelers; Martine I Bakker; Weihsueh A Chiu; Wout Slob
Journal:  Food Chem Toxicol       Date:  2017-10-23       Impact factor: 6.023

7.  Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.

Authors:  Katie Paul Friedman; Matthew Gagne; Lit-Hsin Loo; Panagiotis Karamertzanis; Tatiana Netzeva; Tomasz Sobanski; Jill A Franzosa; Ann M Richard; Ryan R Lougee; Andrea Gissi; Jia-Ying Joey Lee; Michelle Angrish; Jean Lou Dorne; Stiven Foster; Kathleen Raffaele; Tina Bahadori; Maureen R Gwinn; Jason Lambert; Maurice Whelan; Mike Rasenberg; Tara Barton-Maclaren; Russell S Thomas
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

Review 8.  Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide.

Authors:  John Nicolette; Mirjam Luijten; Jennifer C Sasaki; Laura Custer; Michelle Embry; Roland Froetschl; George Johnson; Gladys Ouedraogo; Raja Settivari; Veronique Thybaud; Kerry L Dearfield
Journal:  Environ Mol Mutagen       Date:  2021-11-22       Impact factor: 3.579

9.  Zearalenone in the Intestinal Tissues of Immature Gilts Exposed per os to Mycotoxins.

Authors:  Łukasz Zielonka; Agnieszka Waśkiewicz; Monika Beszterda; Marian Kostecki; Michał Dąbrowski; Kazimierz Obremski; Piotr Goliński; Maciej Gajęcki
Journal:  Toxins (Basel)       Date:  2015-08-18       Impact factor: 4.546

10.  Correlations between Low Doses of Zearalenone, Its Carryover Factor and Estrogen Receptor Expression in Different Segments of the Intestines in Pre-Pubertal Gilts-A Study Protocol.

Authors:  Magdalena Gajęcka; Magdalena Mróz; Paweł Brzuzan; Ewa Onyszek; Łukasz Zielonka; Karolina Lipczyńska-Ilczuk; Katarzyna E Przybyłowicz; Andrzej Babuchowski; Maciej T Gajęcki
Journal:  Toxins (Basel)       Date:  2021-05-26       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.